The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

Merck weighing acquisition of Cubist for more than US$7b: sources

Deal, if announced, would be another multibillion-dollar health care transaction in a banner year for M&A

Published Sun, Dec 7, 2014 · 09:50 PM
Share this article.

New York

DRUGMAKER Merck & Co is in talks to acquire the biopharmaceuticals company Cubist for more than US$7 billion, according to people briefed on the matter.

The deal, if announced, would represent another multibillion-dollar health care transaction in a banner year for mergers and acquisitions in the industry.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here